Professional Documents
Culture Documents
Metoclopramide HCl Antiemetics / Supportive Admin by slow IV or IM. Adult 10 mg 8 hrly. Metoclopramide enhances the motility of the upper GI tract and Nausea & vomiting due to GI disorders, Restlessness, drowsiness, headache,
Care Therapy increases gastric emptying without affecting gastric, biliary or after surgery & cancer chemotherapy. GI diarrhea. Extrapyramidal symptoms eg
Category B: Either animal-reproduction studies pancreatic secretions. It increases duodenal peristalsis which motility disorders. GERD & non ulcer acute dystonic reactions or Parkinsonian
have not demonstrated a foetal risk but there are decreases intestinal transit time, and increases lower oesophageal dyspepsia. Radiodiagnostic procedures in syndrome. Galactorrhoea due to increased
no controlled studies in pregnant women or sphincter tone. It is also a potent central dopamine-receptor the GIT. prolactin secretion.
animal-reproduction studies have shown an antagonist and may also have serotonin-receptor (5-HT3)
adverse effect (other than a decrease in fertility) antagonist properties.
that was not confirmed in controlled studies in Absorption: Rapidly and almost completely absorbed from the GI
women in the 1st trimester (and there is no tract (oral); peak plasma concentrations after 1-2 hr.
evidence of a risk in later trimesters). Distribution: Widely distributed; crosses the blood-brain barrier and
placenta; enters breast milk.
Metabolism: Extensively hepatic.
Excretion: Via urine (as unchanged drug, sulfate or glucuronide
conjugates and metabolites), faeces; 4-6 hr (terminal elimination
half-life).